Aravive, Inc.
Aravive, Inc. (ARAV) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
arav · stock forecast · 18 analysts (3M) · FMP · updated Apr 7, 2025
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Hold
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.25
Consensus
$0.25
+523.4% upside
Low
$0.25
Median: $0.25 · Last Close: $0.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.04 | ↑ 0.40% |
1-day model range: $0.04–$0.04. Peak: $0.04 (+0.40%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ARAV · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-08-21 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-08-03 | EF Hutton | Downgrade ↓ | Buy→Hold |
| 2023-08-03 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2023-08-03 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2023-08-03 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-08-02 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2023-08-02 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2023-08-02 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-08-02 | EF Hutton | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Aravive, Inc. (ARAV) stock. Of the recent 85 rating actions, 1 were upgrades and 16 were downgrades. 18 analysts currently cover ARAV.
Analyst Recommendation Trends
ARAV analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↑ 50.3% YoY
Revenue Next Year
$9M
↑ 69.9% YoY
EPS This Year
$-1.92
EPS Next Year
$-1.25
↓ 34.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast ARAV EPS of $-1.92 for the current fiscal year, based on estimates from 0 analysts. The ARAV revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ARAV stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ARAV price target is $0.25 (+523.4% upside), with an analyst consensus of Hold.
The ARAV short-term stock prediction for tomorrow is $0.04 (+0.40%).
Aravive, Inc. trades on NASDAQ under the ticker ARAV. The ARAV stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 44% of covering analysts.
Frequently asked questions
ARAV forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month ARAV price target is $0.25, with a high forecast of $0.25 and a low of $0.25. The median price target is shown in the chart above when available. This implies +523.4% potential upside from the current price of $0.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.